For example, Wang et al., demonstrated that deletion of the ACOD1 gene in iPSC-derived mesothelin-targeting CAR-Ms enhanced pro-inflammatory activation and reactive oxygen species (ROS) production, significantly boosting antitumour activity in ovarian and pancreatic cancer models (79). This evidence concerns the gene MSLN and familial pancreatic carcinoma.